PRTA 14.4 (+2.49%)
IE00B91XRN20BiotechnologyBiotechnology

Prothena (PRTA) Stock Highlights

14.4 | +2.49%
2024-11-21 03:54:44
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The companys clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinsons disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).

Statistics

Range Today
13.49 14.58
Volume Today 629.7K
Range 1 Year
13.22 41.54
Volume 1 Year 151.41M
Range 3 Year
13.22 79.65
Volume 3 Year 410.14M
Range 10 Year
6.71 79.75
Volume 10 Year 1.1B

Highlights

Market Capitalization 951.91M (small)
Floating Shares 38.35M
Current Price 14.4
Price To Earnings -18.54
Price To Revenue 1.84
Price To Book 1.64
Earnings Per Share -0.94
Payout Ratio 0%

Performance

Latest +2.49%
1 Month -15.14%
3 Months -31.82%
6 Months -36.2%
1 Year -58.15%
3 Years -75.09%
5 Years +34.08%
10 Years -34.9%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.